Written answers
Thursday, 24 November 2022
Department of Health
Medicinal Products
Róisín Shortall (Dublin North West, Social Democrats)
Link to this: Individually | In context | Oireachtas source
318. To ask the Minister for Health further to Parliamentary Question No. 831 of 18 October 2022, the number of times that his Department has met with the Health Products Regulatory Authority, Pharmaceutical Society of Ireland and the HSE to discuss the guidelines and regulations for the sale of codeine containing medicinal products since January 2022; if he has any plans to update the guidelines and regulation in view of widespread misuse of these products; and if he will make a statement on the matter. [58623/22]
Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
I can confirm that my Department officials have met with and will continue to meet officials in the Health Products Regulatory Authority, Pharmaceutical Society of Ireland and HSE to monitor the evolving evidence in relation to codeine-containing medicines, including the merits of any potential further steps to support the safe and effective use of these medicines. This includes full consideration of any policy changes that may be required regarding the regulation of codeine-containing medicinal products.
Róisín Shortall (Dublin North West, Social Democrats)
Link to this: Individually | In context | Oireachtas source
319. To ask the Minister for Health the status of the health technology assessment for evusheld, commissioned by the HSE in April 2022; the expected timeline for a decision on this treatment which has already been authorised by the European Medicines Agency; and if he will make a statement on the matter. [58624/22]
Stephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source
As this is a service matter, I have asked the Health Service Executive to respond to the deputy directly as soon as possible.
No comments